Artificial Intelligence (AI)
- Overview
- Attorneys
The health care sector is rapidly evolving with the integration of artificial intelligence (AI), promising improvements in patient care, operational efficiency, revenue cycle, and medical research. However, this innovation also brings unique legal challenges and regulatory concerns, particularly in clinical settings. Garfunkel Wild’s AI Practice Group is at the forefront of legal innovation in the health care sector, and the unique challenges faced by health care providers as they navigate the complex and rapidly evolving intersection of AI technology and health care. Garfunkel Wild’s AI Practice Group includes attorneys from various disciplines across the firm, including experts from its Health care, Information Technology, Cybersecurity and Data Privacy, Employment Law, Managed Care and Compliance, Litigation & Regulatory practices. The AI Practice Group combines a wide breadth of health care, compliance and technological expertise with practical and strategic guidance, and offers a wide spectrum of legal services to clients in the health care sector, including advising clients on emerging issues in regulatory compliance, reviewing and negotiating AI software agreements, data privacy and security, intellectual property, clinical applications, risk management, litigation and dispute resolution, patient outcomes and the clinical application of AI based technology. At Garfunkel Wild, we recognize that the use of AI in a health care setting extends beyond merely adopting new technology. It involves a commitment to enhancing patient outcomes while simultaneously ensuring compliance with complex rules and regulations.
We proudly serve a diverse range of clients, including hospitals, physician groups, health care systems, biotech companies, and clinical research institutions. Our deep understanding of both the health care and technology sectors allows us to provide targeted, strategic advice that drives innovation, promotes meaningful impact on patient care while safeguarding our clients’ interests.
The health care sector is rapidly evolving with the integration of artificial intelligence (AI), promising improvements in patient care, operational efficiency, revenue cycle, and medical research. However, this innovation also brings unique legal challenges and regulatory concerns, particularly in clinical settings. Garfunkel Wild’s AI Practice Group is at the forefront of legal innovation in the health care sector, and the unique challenges faced by health care providers as they navigate the complex and rapidly evolving intersection of AI technology and health care. Garfunkel Wild’s AI Practice Group includes attorneys from various disciplines across the firm, including experts from its Health care, Information Technology, Cybersecurity and Data Privacy, Employment Law, Managed Care and Compliance, Litigation & Regulatory practices. The AI Practice Group combines a wide breadth of health care, compliance and technological expertise with practical and strategic guidance, and offers a wide spectrum of legal services to clients in the health care sector, including advising clients on emerging issues in regulatory compliance, reviewing and negotiating AI software agreements, data privacy and security, intellectual property, clinical applications, risk management, litigation and dispute resolution, patient outcomes and the clinical application of AI based technology. At Garfunkel Wild, we recognize that the use of AI in a health care setting extends beyond merely adopting new technology. It involves a commitment to enhancing patient outcomes while simultaneously ensuring compliance with complex rules and regulations.
We proudly serve a diverse range of clients, including hospitals, physician groups, health care systems, biotech companies, and clinical research institutions. Our deep understanding of both the health care and technology sectors allows us to provide targeted, strategic advice that drives innovation, promotes meaningful impact on patient care while safeguarding our clients’ interests.